MetLife Investment Management’s Innoviva INVA Stock Holding History

MetLife Investment Management’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$930K	Buy	39,907 +2,683	+7%	+$57.8K	﹤0.01%	1430
2025 Q4	$744K	Hold	37,224	–	–	﹤0.01%	1591
2025 Q3	$679K	Hold	37,224	–	–	﹤0.01%	1664
2025 Q2	$748K	Buy	37,224 +2,752	+8%	+$52.9K	﹤0.01%	1467
2025 Q1	$625K	Sell	34,472 -489	-1%	-$8.77K	﹤0.01%	1604
2024 Q4	$607K	Buy	34,961 +1,731	+5%	+$33.2K	﹤0.01%	1695
2024 Q3	$642K	Hold	33,230	–	–	﹤0.01%	1645
2024 Q2	$545K	Buy	33,230 +157	+0.5%	+$2.44K	﹤0.01%	1679
2024 Q1	$504K	Hold	33,073	–	–	﹤0.01%	1672
2023 Q4	$530K	Hold	33,073	–	–	﹤0.01%	1656
2023 Q3	$430K	Hold	33,073	–	–	﹤0.01%	1719
2023 Q2	$421K	Hold	33,073	–	–	﹤0.01%	1812
2023 Q1	$372K	Hold	33,073	–	–	﹤0.01%	1833
2022 Q4	$438K	Hold	33,073	–	–	﹤0.01%	1725
2022 Q3	$384K	Hold	33,073	–	–	﹤0.01%	1826
2022 Q2	$488K	Buy	33,073 +8,550	+35%	+$140K	﹤0.01%	1681
2022 Q1	$475K	Buy	24,523 +8,903	+57%	+$159K	﹤0.01%	1801
2021 Q4	$269K	Hold	15,620	–	–	﹤0.01%	1866
2021 Q3	$261K	Sell	15,620 -9,998	-39%	-$150K	﹤0.01%	1917
2021 Q2	$344K	Hold	25,618	–	–	﹤0.01%	1800
2021 Q1	$306K	Buy	25,618 +1,520	+6%	+$18.4K	﹤0.01%	1801
2020 Q4	$299K	Sell	24,098 -9,236	-28%	-$99.6K	﹤0.01%	1772
2020 Q3	$348K	Hold	33,334	–	–	﹤0.01%	1553
2020 Q2	$466K	Hold	33,334	–	–	0.01%	1418
2020 Q1	$392K	Hold	33,334	–	–	0.01%	1335
2019 Q4	$472K	Hold	33,334	–	–	﹤0.01%	1494
2019 Q3	$351K	Hold	33,334	–	–	﹤0.01%	1609
2019 Q2	$485K	Hold	33,334	–	–	0.01%	1494
2019 Q1	$468K	Hold	33,334	–	–	0.01%	1488
2018 Q4	$582K	Hold	33,334	–	–	0.01%	1276
2018 Q3	$508K	Hold	33,334	–	–	0.01%	1534
2018 Q2	$460K	Hold	33,334	–	–	0.01%	1449
2018 Q1	$556K	Hold	33,334	–	–	0.01%	1307
2017 Q4	$473K	Buy	+33,334	New	+$445K	0.01%	1422

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MetLife Investment Management's INVA Position: Q1 2026 in Review

MetLife Investment Management increased its Innoviva (INVA) stake by 7.2% in Q1 2026, buying an estimated $57.8K and bringing the position to 39,907 shares worth $930K. The position accounts for ﹤0.01% of the portfolio, ranked #1430.

MetLife Investment Management first reported a position in INVA in Q4 2017 and has held it in 34 quarters since. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

MetLife Investment Management held 39,907 shares of Innoviva worth $930K as of Q1 2026.
MetLife Investment Management bought 2,683 Innoviva shares in Q1 2026, an estimated $57.8K.
Innoviva made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1430 holding.
MetLife Investment Management first reported a position in Innoviva in Q4 2017 and has held it in 34 quarters since.
286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.